Antipicornaviral compounds and methods for their use and preparation
申请人:Agouron Pharmaceuticals, Inc.
公开号:US05962487A1
公开(公告)日:1999-10-05
Picornaviral 3C protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of picornaviral 3C proteases. These compounds, as well as pharmaceutical compositions that contain these compounds, are suitable for treating patients or hosts infected with one or more picornaviruses. Several novel methods and intermediates can be used to prepare the novel picornaviral 3C protease inhibitors of the present invention.